In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
The delay in taking effect is why the "loading phase" of semaglutide is a low dose for a month
Before & Preparation Before you commence Semaglutide treatment, comprehensive labs will be ordered and reviewed during your consultation session with one of our experts
The popularity of semaglutide has grown rapidly in recent years
Keep in mind that all three brand name drugs contain the active ingredient semaglutide